Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for medical industry researchers · Sunday, October 21, 2018 · 465,685,859 Articles · 3+ Million Readers
Home  •••  Topics  •  Countries  •  U.S. States  •  World Media Directory  •  Events
Autism News  •••  Topics  •  Countries  •  U.S. States  •  Events

Madagascar Autism News Monitoring Service


Featured Releases

Got News to Share? · Submit · See All

Load more autism news or search news using your own keywords. There are 465,685,859 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Submit News & Events

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

Have an event? Add it to our Events & Conferences Directory.

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 09/22/2018

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Healthcare & Pharmaceuticals Events

Got Events to Share? · Submit · See All

92nd Annual Clinical Reviews 2018

Date: 22-Oct-18 to 24-Oct-18
Location: Rochester / United States
This course is offered twice, October 22-24 and again November 5-7. This course is designed for physicians, nurse practitioners, physician assistants and nurses practicing in primary care, family medicine and internal medicine. Course Highlights: -Concise didactic -Content focused on the needs of the primary care provider in the clinical -Dedicated question and answer sessions throughout the -Pre-course ABFM Knowledge Self- -Breakout sessions for personalized course -Course app containing all presentations with note-taking Learning Objectives: Upon conclusion of this program, participants should be able to: -Formulate new treatment options for the management of patients with poorly controlled type 2 diabetes -...

2nd Annual NASH Summit Europe

Date: 22-Oct-18 to 24-Oct-18
Location: Frankfurt / Germany
Built from research with the FDA, EMA and Gilead, the 2nd Annual NASH Summit Europe will once again elevate industry-to-industry dialogue and reveal leading insights in overcoming the hurdles limiting NASH therapeutic success. Join the NASH community as they collectively address the biggest challenges in NASH through a tighter lens including the potential for stand-alone versus combination therapeutics, the genetic drivers influencing disease heterogeneity and the future payer and reimbursement landscape. Hear from 22 stakeholders including Pfizer, Novartis and MedImmune as this exclusively drug development driven forum equips you with the connections and actionable takeaways you need to capture one of many market opportunities for a successful NASH candidate.

Gene Therapy for Rare Disorders Europe Summit

Date: 22-Oct-18 to 24-Oct-18
Location: United Kingdom
Dedicated to Realizing the Commercial Potential of Gene Now is a crucial time for the gene therapy field, as the ripple effects of the pioneering first US gene therapy approval are being felt globally, setting new benchmarks and posing unexpected questions. Rather than early stage basic science, the Gene Therapy for Rare Disorders Europe Conference is solely devoted to addressing the latest clinical, manufacturing, regulatory and commercialization challenges facing this rapidly evolving field. This is a comprehensive guide to define your commercial path forward. Here’s a snapshot of the companies who attended last year: Pfizer – Shire – Lysogene – BioMarin – Novasep – Horama – Orchard Therapeutics – Avrobio – Genzyme – Astellas – uniQure – Syneos Health – REGENXBIO – Chiesi – ...

Precision CRISPR: Drug Discovery and Gene Therapy London 2018

Date: 22-Oct-18 to 24-Oct-18
Location: United Kingdom
Precision CRISPR: Drug Development & Gene Therapy Congress returns for the 3rd time, just in time to face the building excitement in getting CRISPR gene therapy into the clinic. Take a look at the conference program and engage with this community today: https://bit.ly/ Through a dynamic program of focused sessions, interactive discussions and networking opportunities, you will leave this meeting with a deep understanding of: - the challenges in delivery & reducing off-target effects in ex vivo & in vivo gene - how the likes of GSK, Novartis, AstraZeneca and more, work towards improving the efficacy of functional screening and drug - the most recent gene editing techniques and Cas variants poised to make precise gene editing all that more ...

Global Regulatory Affairs Summit

Date: 23-Oct-18 to 25-Oct-18
Location: Berlin / Germany
Whatever your international hurdle, our industry and authority experts have the answers...

Genotoxic Impurities

Date: 23-Oct-18 to 24-Oct-18
Location: Berlin / Germany
The brightest industry and regulatory minds shine a light on identification and control of GTIs. Build a complete strategy for potential genotoxic impurities in your pharmaceuticals.

eyeforpharma Patient Summit USA

Date: 23-Oct-18 to 24-Oct-18
Patient value has now become synonymous with business value. Companies listening to the growing patient voice and incorporating those insights into the design of products, trials and strategy are being rewarded with higher uptake and better outcomes. Patients are no longer just recipients of care, they are also active partners in the design and masters of their own care decisions. Fortunately for pharma, it’s never been easier to speak to patients. Digital avenues, social media engaged advocacy groups and, most importantly, a receptive audience means pharma has the opportunity and the technology to interact with patients and build what they want. Opportunities are aplenty for those willing to walk the talk on patient engagement. Are you a walker or a talker?

Targeted Protein Degradation Summit

Date: 23-Oct-18 to 25-Oct-18
Location: Boston / United States
As the drug discovery opportunity hidden within the proteome opens up and gains tremendous investment, the inaugural Targeted Protein Degradation Summit 2018 is a dedicated scientific and networking forum for large pharma, innovative biotech and research institutes to capitalize on this emerging therapeutic class. Focus on understanding the selectivity and speed of binding, improve the rationale design of bifunctional molecules and overcome critical chemistry challenges to translate these unique small molecules into safe and effective clinical therapeutics. Built with large pharma and biotech insight, the TPD 2018 is specifically focused on optimizing and accelerating the discovery, translational research and ultimately clinical development of targeted protein degradation therapies ...

Immune Checkpoint Inhibitors in the Treatment of Stage III NSCLC, Oct 23

Date: 23-Oct-18 to 23-Oct-18
Location: Orlando / United States
Join us on Tuesday, October 23 at the Orlando World Center Marriott for a clinic-focused symposium during AMCP Nexus 2018. Explore the pharmacist’s critical role in the optimal integration of checkpoint inhibitors into the care of patients with unresectable stage III NSCLC at this dynamic satellite. Attendees will have the opportunity to text questions to expert faculty, Ali McBride, PharmD, MS, BCOP, FAzPA; Sandra Cuellar, PharmD, BCOP; and Tarek M. Mekhail, MD, MSc, FRCSI, FRCSEd, and get practical guidance on the application of immunotherapy approaches to early-stage NSCLC. This satellite symposium is complimentary to attend and is ACPE-certified for 1.5 contact hours. For more information and to register, go to https://events.clinicaloptions.com/oncology/Nexus2018.